Chiauranib Capsule

chiauranib · Chipscreen Biosciences, Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Chiauranib Capsule, covering 2024-12-09 to 2024-12-09. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer [Phase 3]